Translate this page into:
Retraction: Assessment of intracranial metastases from neuroendocrine tumors/carcinoma
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
The article entitled “Assessment of intracranial metastases from neuroendocrine tumors/carcinoma” published on pages 435-439, volume 7, issue 3, in the Journal of Neurosciences in Rural Practice has been retracted on the request of the author, Dr. Kazuei Hoshi.[1] Dr. Kazuei and Dr. Koichi were unaware of the submission of this article. The article contained fabricated data and a substantial amount of material plagiarised from the article that was published in Volume 16 of the journal BMC Cancer, as “Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain”.[2]
REFERENCES
- Assessment of intracranial metastases from neuroendocrine tumors/carcinoma. J Neurosci Rural Pract. 2016;7:435-439. doi:10.4103/0976-3147.182779
- [Google Scholar]
- Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain. BMC Cancer. 2016;16:36. doi: 10.1186/s12885-015-1999-x
- [Google Scholar]
